Ophthalmic Formulation

Thomas Millar (Inventor), Burkhardt Schuett (Inventor)

Research output: Patent

Abstract

Disclosed herein is an ophthalmic formulation comprising a compound of formula (I) wherein R.sup.1 is a linear or branched C.sub.9-C.sub.33 alkyl or a linear or branched C.sub.9-C.sub.33 alkenyl with 1 to 4 double bonds; R.sup.2 is a linear or branched C.sub.9-C.sub.19 alkyl or a linear or branched C.sub.9-C.sub.19 alkenyl with 1 to 4 double bonds; and an ophthalmologically acceptable carrier.
Original languageEnglish
Patent numberUS20200190015A1
Filing date18/07/19
Publication statusPublished - 2020

Fingerprint

Dive into the research topics of 'Ophthalmic Formulation'. Together they form a unique fingerprint.

Cite this